98 related articles for article (PubMed ID: 19147273)
1. Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
Prieto D
Eur Urol; 2010 Feb; 57(2):349. PubMed ID: 19147273
[No Abstract] [Full Text] [Related]
2. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity.
Gratzke C; Christ GJ; Stief CG; Andersson KE; Hedlund P
Eur Urol; 2010 Feb; 57(2):342-8. PubMed ID: 19147270
[TBL] [Abstract][Full Text] [Related]
3. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.
Ghasemi M; Sadeghipour H; Shafaroodi H; Nezami BG; Gholipour T; Hajrasouliha AR; Tavakoli S; Nobakht M; Moore KP; Mani AR; Dehpour AR
Br J Pharmacol; 2007 Jul; 151(5):591-601. PubMed ID: 17486141
[TBL] [Abstract][Full Text] [Related]
4. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.
Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of nonadrenergic noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum.
Vural IM; Ozturk GS; Sarioglu Y
J Sex Med; 2009 Mar; 6(3):717-29. PubMed ID: 19175867
[TBL] [Abstract][Full Text] [Related]
6. Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
Ghasemi M; Sadeghipour H; Dehpour AR
BJU Int; 2007 Dec; 100(6):1385-90. PubMed ID: 17850365
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid immune and vascular signaling.
Stefano GB
Acta Pharmacol Sin; 2000 Dec; 21(12):1071-81. PubMed ID: 11603279
[No Abstract] [Full Text] [Related]
8. The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.
Smid SD; Bjorklund CK; Svensson KM; Heigis S; Revesz A
Eur J Pharmacol; 2007 Dec; 575(1-3):168-76. PubMed ID: 17706636
[TBL] [Abstract][Full Text] [Related]
9. Effects of hypertension on vasorelaxation to endocannabinoids in vitro.
Wheal AJ; Randall MD
Eur J Pharmacol; 2009 Jan; 603(1-3):79-85. PubMed ID: 19100733
[TBL] [Abstract][Full Text] [Related]
10. Endothelial vasodilatory cannabinoid receptor in the human pulmonary artery: a future option in the therapy of pulmonary hypertension?
Hornig B
J Hypertens; 2007 Nov; 25(11):2202-3. PubMed ID: 17921811
[No Abstract] [Full Text] [Related]
11. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Barana A; Amorós I; Caballero R; Gómez R; Osuna L; Lillo MP; Blázquez C; Guzmán M; Delpón E; Tamargo J
Cardiovasc Res; 2010 Jan; 85(1):56-67. PubMed ID: 19689982
[TBL] [Abstract][Full Text] [Related]
12. Drug development. Drugs inspired by a drug.
Marx J
Science; 2006 Jan; 311(5759):322-5. PubMed ID: 16424309
[No Abstract] [Full Text] [Related]
13. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
14. The role of the endogenous cannabinoid system in peripheral analgesia.
Guindon J; Beaulieu P
Curr Mol Pharmacol; 2009 Jan; 2(1):134-9. PubMed ID: 20021453
[TBL] [Abstract][Full Text] [Related]
15. Dual effect of anandamide on rat placenta nitric oxide synthesis.
Cella M; Leguizamón GF; Sordelli MS; Cervini M; Guadagnoli T; Ribeiro ML; Franchi AM; Farina MG
Placenta; 2008 Aug; 29(8):699-707. PubMed ID: 18561998
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids and the gut: new developments and emerging concepts.
Izzo AA; Sharkey KA
Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
[TBL] [Abstract][Full Text] [Related]
17. The endogenous cannabinoid system and the treatment of marijuana dependence.
Piomelli D
Neuropharmacology; 2004; 47 Suppl 1():359-67. PubMed ID: 15464150
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid in the nucleus accumbens enhances the intake of palatable solution.
Shinohara Y; Inui T; Yamamoto T; Shimura T
Neuroreport; 2009 Oct; 20(15):1382-5. PubMed ID: 19734811
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Lambert DM; Fowler CJ
J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
